PR Bullet Points.....
Eleven (11) Patients in NY hospital
=========================
# All treated patients were in Intensive Care Units (ICU) because of acute respiratory failure
# eight of whom were intubated (placed on mechanical ventilation).
# One patient was not intubated because of poor baseline pulmonary status (history of lung cancer and had undergone bilateral upper lobectomy)
# Seven patients were organ-transplant recipients (six patients were renal-transplant recipients and one patient had a history of heart transplant) and were on immunosuppressive regimen.
# Ten patients were on dialysis
# nine were on vasopressors during hospitalization.
Despite their pre-existing and severe conditions, we believe we were able to save the lives of four patients.
All patient blood samples were evaluated and important powerful results from the effect of leronlimab were demonstrated in almost all of these patients. This data has been submitted to a prestigious journal and we expect the publication on Friday, May 1.
Twenty-three (23) patients in Southern California hospital
==========================================
# Six patients were in critical condition (intubated)
# 17 patients were severely-ill, needing oxygen support
# No death was reported
# Out of 6 critical patients, all were intubated patients
# 3 were extubated (taken off ventilator)
# 2 patients remain relatively stable and still breathing with the assistance of a ventilator
# one patient has shown deterioration in respiratory parameters
Of 17 severe condition (but not critical) patients
11 patients demonstrated improvement in respiratory parameters
8 of them were discharged from hospital, including one patient in the news, Samantha Mottet)
2 patients remain relatively stable
2 have shown deterioration in respiratory parameters
information is pending for 2 recently treated patients.
Three (3) patients in Georgia hospital
===========================
# All three ICU patients were intubated
# two of them had renal failure at the start of leronlimab treatment.
2 were extubated (taken off ventilator)
1 patient remains on a ventilator but improving.
One (1) patient in another NY hospital
===========================
Patient was taken off oxygen and discharged from hospital after leronlimab treatment.
One (1) patient in Northern California hospital
=================================
Patient is now weaning from ventilator and transferred to rehabilitation hospital.
Updates are pending for 10 other patients. Five additional patients have been approved to receive leronlimab under eINDs, which increases the total eINDs approved by the FDA to 54 patients.
Eleven (11) Patients in NY hospital
=========================
# All treated patients were in Intensive Care Units (ICU) because of acute respiratory failure
# eight of whom were intubated (placed on mechanical ventilation).
# One patient was not intubated because of poor baseline pulmonary status (history of lung cancer and had undergone bilateral upper lobectomy)
# Seven patients were organ-transplant recipients (six patients were renal-transplant recipients and one patient had a history of heart transplant) and were on immunosuppressive regimen.
# Ten patients were on dialysis
# nine were on vasopressors during hospitalization.
Despite their pre-existing and severe conditions, we believe we were able to save the lives of four patients.
All patient blood samples were evaluated and important powerful results from the effect of leronlimab were demonstrated in almost all of these patients. This data has been submitted to a prestigious journal and we expect the publication on Friday, May 1.
Twenty-three (23) patients in Southern California hospital
==========================================
# Six patients were in critical condition (intubated)
# 17 patients were severely-ill, needing oxygen support
# No death was reported
# Out of 6 critical patients, all were intubated patients
# 3 were extubated (taken off ventilator)
# 2 patients remain relatively stable and still breathing with the assistance of a ventilator
# one patient has shown deterioration in respiratory parameters
Of 17 severe condition (but not critical) patients
11 patients demonstrated improvement in respiratory parameters
8 of them were discharged from hospital, including one patient in the news, Samantha Mottet)
2 patients remain relatively stable
2 have shown deterioration in respiratory parameters
information is pending for 2 recently treated patients.
Three (3) patients in Georgia hospital
===========================
# All three ICU patients were intubated
# two of them had renal failure at the start of leronlimab treatment.
2 were extubated (taken off ventilator)
1 patient remains on a ventilator but improving.
One (1) patient in another NY hospital
===========================
Patient was taken off oxygen and discharged from hospital after leronlimab treatment.
One (1) patient in Northern California hospital
=================================
Patient is now weaning from ventilator and transferred to rehabilitation hospital.
Updates are pending for 10 other patients. Five additional patients have been approved to receive leronlimab under eINDs, which increases the total eINDs approved by the FDA to 54 patients.
2
